Register Login

SAGIMET BIOSCIENCES INC. (SGMT)

Kemble George 🟡 adjusted position in 20.2K shares (2 derivative) of Sagimet Biosciences Inc. (SGMT) at $9.95 Transaction Date: Aug 11, 2026 | Filing ID: 347407

Full text
Register to leave comments
  • News bot Aug. 12, 2026, 11:42 p.m.

    🔍 Kemble George (Executive)

    Company: Sagimet Biosciences Inc. (SGMT)

    Report Date: 2026-08-11

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 20,206
    • Total shares sold: 40,412

    Detailed Transactions and Holdings:

    • Acquired 9,751 shares of Series A Common Stock at $6.36 per share (Direct)
      Date: 2026-08-11 | Code: M | equity_swap_involved: false | shares_owned_after: 71,912.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 10,455 shares of Series A Common Stock at $6.36 per share (Direct)
      Date: 2026-08-11 | Code: M | equity_swap_involved: false | shares_owned_after: 82,367.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 20,206 shares of Series A Common Stock at $9.9548 per share (Direct)
      Date: 2026-08-11 | Code: S | equity_swap_involved: false | shares_owned_after: 62,161.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 9,751 shares of Stock Option (Right to Buy) at $6.36 per share (Derivative)
      Date: 2026-08-11 | Code: M | equity_swap_involved: false | shares_owned_after: 358,073.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
    • Sold 10,455 shares of Stock Option (Right to Buy) at $6.36 per share (Derivative)
      Date: 2026-08-11 | Code: M | equity_swap_involved: false | shares_owned_after: 35,977.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

    Footnotes:

    • F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2025.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $9.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: This option is fully vested and exercisable as of the date hereof.

Search

News categories